George Lott, CTPro, CCP-C

George Lott, the visionary CEO and Founder of Biovivium Strategies, is a dynamic force in the biotech and pharmaceutical industry. With a steadfast commitment to innovation, George leads our team in reshaping industry norms. His strategic approach and dedication to advancing global health foster excellence and propel Biovivium towards unparalleled achievements.

Being that he started his early career as a Paramedic, George brings a distinctive viewpoint and a profound comprehension of patient care to his position. Patients always remain his top priority, influencing his choices and fueling his dedication to enhancing healthcare results. Holding certification as a Clinical Trials Management Professional (CTPro) for the US & EU, George utilizes more than a decade of broad experience in global clinical operations, autologous cell therapy, business development, and Organ & Tissue Transplant. His guidance and proficiency drive Biovivium to the forefront of the biotech sector, shaping a promising future for healthcare on a global scale.

Outside the corporate setting, George finds happiness in spending time with his husband Sean and their three dogs, along with being an avid freshwater aquarium enthusiast. This personal contentment and the backing of his loved ones are the driving forces behind his ambition to innovate and steer Biovivium towards even greater accomplishments.